We reviewed the literature on the use of margins in radiotherapy of patients with prostate
cancer, focusing on different options for image guidance (IG) and technical issues. The …

Stereotactic body radiotherapy (SBRT) for prostate cancer (PCa) is gaining interest by the
recent publication of the first phase III trials on prostate SBRT and the promising results of …

The use of stereotactic body radiotherapy (SBRT) for localised prostate cancer is now
supported by a substantial body of non-randomised data, with medium-term outcomes …

Purpose The aim of this study was to evaluate the feasibility and dose distribution of two
different stereotactic body radiation therapy (SBRT) techniques, isocentric RapidArc (RA) …

Background The accuracy of the Elekta Clarity™ three-dimensional ultrasound system
(3DUS) was assessed for prostate positioning and compared to seed-and bone-based …

Simple Summary By delivering escalated doses to biologically defined sub-volumes within a
target, focal boost radiotherapy is expected to enable an elevated tumor control without an …

Purpose This study aimed to report the early toxicity results of a prospective clinical trial of
prostate stereotactic body radiation therapy (SBRT) to the entire prostate with a …

Introduction Dose escalation to dominant intraprostatic lesions (DILs) is a novel method to
increase the therapeutic ratio in localised prostate cancer. The Stereotactic Prostate …

Purpose Stereotactic body radiation therapy (SBRT) is increasingly used as a definitive
treatment option for patients with prostate adenocarcinoma. The aim of this study was to …

To investigate the dosimetric impact of intrafraction translation and rotation motion of the
prostate, as extracted from daily acquired post-treatment 3D cine-MR based on soft-tissue …